Study reveals activity of navtemadlin in glioblastoma, points to possible treatment improvements
Glioblastoma is the most aggressive and most common malignant brain cancer in adults. It is currently treated with surgery, ...
Platform trials streamline ALS therapy evaluation by rapidly ruling out ineffective drugs
Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...
Becker's Hospital Review4h
FDA approves generic cancer treatment for 2026 availability
The FDA has approved a generic version of lenalidomide, a drug used to treat multiple myeloma and myelodysplastic syndromes, with availability set for Jan. 31, 2026.
Health Affairs23h
Demographic Variation In US Outpatient Hydroxychloroquine And Ivermectin Use During The COVID-19 Pandemic
As COVID-19 surged across the US starting in 2020, so too did the use of repurposed medications such as hydroxychloroquine and ivermectin to treat COVID-19 infections. Use of these medications ...